Digestives & Intestinal Remedies - North America

North America

Highlights

In North America, the Digestives & Intestinal Remedies market market recorded a revenue of US$2.52bn in 2024.
It is projected to experience an annual growth rate of 1.66% (CAGR 2024-2029).
Comparatively, China generates the highest revenue in this market, with US$4.41bn in 2024.
When considering per capita figures, the revenue generated per person in North America amounts to US$4.94 in 2024.
In North America, the Digestives & Intestinal Remedies market is witnessing a growing demand for natural and herbal products.

Key regions:

Market definitionIn-Scope/Out-of-scopeMarket structureReportsMethodology

The Digestives & Intestinal Remedies market in North America is experiencing steady growth and development.

Customer preferences: Customers in North America are increasingly seeking natural and organic remedies for digestive and intestinal issues. This preference for natural products is driven by a growing awareness of the potential side effects of conventional medications and a desire for more holistic approaches to healthcare. Additionally, there is a rising demand for products that address specific digestive concerns, such as acid reflux, bloating, and irritable bowel syndrome.

Trends in the market: One major trend in the Digestives & Intestinal Remedies market in North America is the increasing popularity of probiotics. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They are believed to restore the natural balance of bacteria in the gut and improve overall digestive function. Probiotic supplements and foods, such as yogurt and kefir, have gained significant traction among consumers in North America.Another trend in the market is the growing use of herbal remedies. Many consumers are turning to herbal supplements, such as ginger, peppermint, and chamomile, to alleviate digestive symptoms. These natural remedies are perceived as safer alternatives to conventional medications and are often associated with fewer side effects.

Local special circumstances: The North American market for Digestives & Intestinal Remedies is characterized by a high level of competition. There are numerous local and international players in the market, offering a wide range of products to cater to diverse customer preferences. This competitive landscape drives innovation and product development, as companies strive to differentiate themselves and capture market share.

Underlying macroeconomic factors: The growth of the Digestives & Intestinal Remedies market in North America is influenced by several macroeconomic factors. Firstly, the increasing prevalence of digestive disorders, such as gastroesophageal reflux disease (GERD) and irritable bowel syndrome (IBS), is driving the demand for remedies. Changing dietary habits, stress, and sedentary lifestyles contribute to the rising incidence of these conditions.Secondly, the aging population in North America is a significant factor driving market growth. Older adults are more prone to digestive issues and are seeking remedies to manage their symptoms and improve their quality of life. As the population continues to age, the demand for Digestives & Intestinal Remedies is expected to increase.Lastly, the growing focus on preventive healthcare is fueling the demand for digestive health products. Consumers are becoming more proactive in managing their health and are willing to invest in products that promote overall well-being. This trend is expected to drive the growth of the Digestives & Intestinal Remedies market in North America in the coming years.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.